GRPN Archives - Page 3 of 6 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: Big News for KRFT & More

Kraft (KRFT) to Merge With Heinz

–

In a move that will effectively create the third-biggest food company on the North American continent, it has been announced that Kraft Foods Group Inc. (KRFT) and H.J. Heinz Co. will merge. 3G Capital and Berkshire Hathaway, which bought Heinz for $23B and took it private back in 2013, will be orchestrating the deal.

As a result of this development, KRFT is gapping up monstrously in the premarket to the tune of more than 30% Generally when we see a stock soar on news like this, our first instinct is to continually scan for a dip-and-rip scenario once the session commences. When the rip does occur, we’re going to be looking to April $75-85 Calls for intraday options trading possibilities.

Kraft Foods, H.J. Heinz to Merge (Wed 8:18AM EDT)

Social Media Sector on Watch

Despite uncertainly over whether interest rates will be raised this year causing a general downturn in the markets, social media stocks appeared to be an exception yesterday.

We’re always looking for trends to exploit for options trading, and should Facebook, Inc. FB, Twitter, Inc. TWTR, and LinkedIn Corp. LNKD continue their hot hand this week, we could see some nice action in the following contracts:

FB Weekly $84-86 Calls
TWTR Weekly $50-52 Calls
LNKD Weekly $260-265 Calls

Vascular Biogenics, Inc. VBLT

VBLT is another gapper this morning that has surged in the premarket following the company Q4 earnings release. The stock briefly spiked to its 50DMA of 8.65 in early trading, and appears as if it will open in the 6.50’s.

We will look to see VBLT re-break the $7-mark once the session kicks off, as there is a large gap on the chart as we point out below, the filling of which would make for some highly notable gains. It’s definitely a stock we want to keep on our radar as we cruise through mid-week.

Extended Watchlist:
KFX, FXCM, ONCY, BLRX, MRNS, GRPN

Blue Horseshoe Stocks: ISR, Bottom Plays & More

IsoRay, Inc. ISR

We first began tracking ISR back in early October as a potential bottom play, and just a few sessions subsequent to our first mention, we would witness a low of 1.22 (10/16).

It took just a couple of weeks for us to ride ISR to a 66% gain as it ran to a high of 2.03 at the end of October. It consolidated down from that level, and for the past month or so the stock has been trading channel between 1.50-1.70.

ISR is catching our attention once again this morning, as we picked up on a new update over the press wire regarding the company’s Cesium-131 low-dose radiation therapy for brain cancer sufferers (Learn More About Cesium-131).

The Barrow Neurological Institute conducted studies with 27 patients with several variations of brain cancer, and the company is reporting that there was no recurrence of the disease on the treated sites in 26 out of the 27 candidates, where other treatments had failed. >> Read PR

We’re going to be interested to see how the stock picks up trading following the holiday week, especially with such an encouraging piece of news out in the premarket. So far, the ISR has gone as high as 2.08 in preliminary trading this morning. We could be looking at a dip-and-scenario once the session commences; to remain interested we’ll want to see support hold at a minimum of 1.89 as that would mark a 50% retrace from the current premarket range.

Potential Bottom Plays

AEterna Zentaris, Inc. AEZS absolutely fell off a cliff back in early November, following FDA denial of a New Drug Application AEZS had submitted. The stock has spent the intervening time bottoming out, and it is now trading at all-time lows. This is exactly the sort of situation that sends us into “vulture-mode”, where we’re on the lookout for any signs of recovery after a stock has been hammered down.

Frontline, Ltd. FRO is a stock that is in the process of coming off of a recent bottom, and is showing signs of life here in today’s premarket, currently trading in the mid-1.30’s.

Extended Watchlist:
JNUG, GRPN, AG, ONNN

Blue Horseshoe Stocks: FCGD, PZOO Updates

First Columbia Gold Corp. FCGD

FCGD continued to push its limits on Friday; if you recall, the low we observed following our in our initial report last Monday was .075. We witnessed a subsequent run to .098, which was followed by a pullback to support at .076. From that level on Friday, FCGD went to to set a new high in to the close (.105), an intraday gain of 38% on nearly twice the monthly average volume.

LINKS:

Our Exclusive Interview with FCGD’s New CEO Jason Castenir on Thursday provided over 20 minutes of exclusive content on FCGD, so go check it out.

View a copy of Monday’s Initial FCGD Report Here

MORE INFO @ FirstColombiaGold.com
or connect with FCGD on Facebook, Twitter and YouTube

Pazoo, Inc. PZOO

We’ve kept an active eye on PZOO since we introduced it to our reports two Mondays ago at a low of .0225. The stock has since established a higher level of support above the 50DMA, which was something we were looking to have happen.

We also saw PZOO achieve a new high last week, hitting .038 (A 69% increase from our observed low) a mark that will act as key resistance moving forward.

The company set a new traffic milestone for their online health and wellness portal as well, updating us of the achievement on Thursday:

WHIPPANY, NJ / ACCESSWIRE / October 30, 2014 / Pazoo, Inc. (PZOO) (German WKN#: A1J3DK) is pleased to report that traffic surged passed the previous high of 203,000 visitors in one day (previously recorded May of 2014) to 239,786 on October 27, 2014, as reported by Google Analytics. >> VIEW PR

Groupon, Inc. GRPN

We also need to pat ourselves on the back for taking a timely look at GRPN on Friday and mentioning it in our extended watchlist. The stock surged from a low of 6.45 and ended up peaking at 7.42, gaining 16.5% intraday on almost six times the one-month average volume.

That’s quite a respectable single-session spike from a stock in this price range.

Extended Watchlist:
GERN, OIBR, ARNA, MNDO, NYMX(Gap-down, Watching for Possible Reversal)

Blue Horseshoe Stocks: Thursday’s Top Movers, FCGD Update & More

First Columbia Gold Corp. FCGD

After zeroing in on FCGD in yesterday’s premarket report, the activity that followed was encouraging. The stock traded up on light volume, to the tune of a 30% intraday jump from .075 to .098; a good indicator of the kind of reactions and potential gains we can expect from it moving forward. Any increased buying pressure has a chance to produce price increases even more drastic than what we saw yesterday.

Don’t forget that we conducted an exclusive interview with FCGD’s new CEO Jason Castenir yesterday through our sister site, Stock Traders Talk. Follow the link above or the graphic below to hear over 20 minutes of exclusive content on FCGD straight from the source.

Here we point out a few of the key highlights of the FCGD Chart:

MORE INFO @ FirstColombiaGold.com
or connect with FCGD on Facebook, Twitter and YouTube

Metalico, Inc. MEA

With our primary focus being on FCGD yesterday we didn’t have a chance to congratulate our members who were able to take advantage of one of our ideas from the prior session. After we caught MEA on Wednesday’s Extended Watchlist, the stock blasted off from a low of .381 all the way .667, a solid 75% intraday run.

Yesterday the stock fell back to bounce off of support at .53 and made a modest rebound to .59.

Winners From Yesterday’s Stock Tracker

We try to remind our readers as much as we can, that whether you’re a subscriber to our daily email reports, or view our content on Third-Party websites, that it’s always important to check our blog at Blue Horseshoe Stocks on a daily basis.

Yesterday provided a good example of why; with our main attention going to FCGD, the additional symbols on our radar that would normally go into an Extended Watchlist, were relegated to the sidebar tracker on Blue Horseshoe Stocks, as pictured in the following snapshot taken yesterday afternoon:

As you can see, anyone who visited our page during the day yesterday could have caught any one of a number big movers:

FRAZ – Range: .11-.49 – Max Gain: +345%
HKUP – Range: .0026-.0094 – Max Gain: +261%
BANJ – Range: .185-.39 – Max Gain: +111%
CDTI – Range: 2.22-3.98 – Max Gain: +78%

Extended Watchlist:
OIBR, GRPN, JNUG, FLEX

Blue Horseshoe Stocks: VIDG, PBR Calls & More

Vid3G, Inc. VIDG

We’re bringing VIDG up as an item of interest this morning as a stock that is coming off of its 52-week lows, and our subscribers are well aware, we’ve seen plays like these produce exponential gains on the rebound many times in the past.

Yesterday’s session saw a rapid swing up from that annual low (.01), and VIDG managed to break through its 50DMA at .015, as well as maintain that level into the close. Another session of higher highs and higher lows would go a long way toward confirming this uptrend. We’d like to see that previous area of resistance hold as support moving ahead, and based on a number of indicators on the chart, the chance for a bounce to .02 or better is certainly present; VIDG has produced spikes of that magnitude several times this year.

We illustrate this and other points on the chart in the following video, so take a look:

Petroleo Brasiliero S.A. (Petrobras) PBR – Options

On Friday, we mentioned our interest in the PBR $16 Calls for this week, and included a reminder in yesterday morning’s report as well. We’ve become quite adept at playing the PBR options chain over the last several months, and these alerts simply confirm that.

The action on the $16 Weekly Calls indeed proved to be significant as the trading week commenced, with yesterday’s session seeing an intraday move from .20-.38, good for gains of up to 90% A great way to kick things off for these contracts which are now in the money, and we’ll be sticking with the $16’s as the week presses on.

Should PBR approach the 16.35-level, we would then have to consider moving up our strike price.

IsoRay, Inc. ISR

We also want to throw ISR into the mix this morning, as the stock is gapping up off of a relative bottom on some exciting news this morning, so we wanted to enter this into the log as an interesting play that we’re going to want to keep an eye on.

RICHLAND, WA, Aug 05, 2014 (Marketwired via COMTEX) — IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the publication of the first major peer reviewed study showing superior results using IsoRay’s Cesium-131 seeds in the treatment of metastatic brain cancer. >>>FULL PR

Extended Watchlist:
ODP, ESI, GRPN, MNI, KORS